| SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants F Tea, A Ospina Stella, A Aggarwal, D Ross Darley, D Pilli, D Vitale, ... PLoS medicine 18 (7), e1003656, 2021 | 120 | 2021 |
| Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia A Aggarwal, AO Stella, G Walker, A Akerman, C Esneau, V Milogiannakis, ... Nature Microbiology 7 (6), 896-908, 2022 | 97* | 2022 |
| SARS-CoV-2 Omicron BA. 5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern A Aggarwal, A Akerman, V Milogiannakis, MR Silva, G Walker, AO Stella, ... EBioMedicine 84, 2022 | 81 | 2022 |
| Systematic review of the impact of point‐of‐care testing for influenza on the outcomes of patients with acute respiratory tract infection E Egilmezer, GJ Walker, P Bakthavathsalam, JR Peterson, JJ Gooding, ... Reviews in medical virology 28 (5), e1995, 2018 | 67 | 2018 |
| SARS‐CoV‐2 in human milk is inactivated by Holder pasteurisation but not cold storage GJ Walker, V Clifford, N Bansal, AO Stella, S Turville, S Stelzer‐Braid, ... Journal of Paediatrics and Child Health 56 (12), 1872-1874, 2020 | 64 | 2020 |
| Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability DL Burnett, KJL Jackson, DB Langley, A Aggarwal, AO Stella, ... Immunity 54 (12), 2908-2921. e6, 2021 | 44 | 2021 |
| Evaluation of commercially available viral transport medium (VTM) for SARS-CoV-2 inactivation and use in point-of-care (POC) testing D Van Bockel, CML Munier, S Turville, SG Badman, G Walker, AO Stella, ... Viruses 12 (11), 1208, 2020 | 39 | 2020 |
| SARS Coronavirus-2 microneutralisation and commercial serological assays correlated closely for some but not all enzyme immunoassays GJ Walker, Z Naing, A Ospina Stella, M Yeang, J Caguicla, ... Viruses 13 (2), 247, 2021 | 36 | 2021 |
| Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes S Stelzer-Braid, GJ Walker, A Aggarwal, SR Isaacs, M Yeang, Z Naing, ... Pathology 52 (7), 760-763, 2020 | 29 | 2020 |
| Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies R Rouet, O Mazigi, GJ Walker, DB Langley, M Sobti, P Schofield, ... MAbs 13 (1), 1922134, 2021 | 25 | 2021 |
| Emergence and antibody evasion of BQ, BA. 2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level A Akerman, V Milogiannakis, T Jean, C Esneau, MR Silva, T Ison, ... eBioMedicine 90, 2023 | 23 | 2023 |
| Viruses associated with acute respiratory infection in a community‐based cohort of healthy New Zealand children GJ Walker, S Stelzer‐Braid, C Shorter, C Honeywill, M Wynn, ... Journal of medical virology 94 (2), 454-460, 2022 | 23 | 2022 |
| Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients R Rouet, JY Henry, MD Johansen, M Sobti, H Balachandran, DB Langley, ... Nature Communications 14 (1), 687, 2023 | 21 | 2023 |
| Proficiency testing for the detection of Middle East respiratory syndrome coronavirus demonstrates global capacity to detect Middle East respiratory syndrome coronavirus T Theis, KA Lau, JL Gray, CJ Oxenford, GJ Walker, WD Rawlinson Journal of Medical Virology 90 (12), 1827-1833, 2018 | 7 | 2018 |
| Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2 E Bowden-Reid, S Ledger, Y Zhang, F Di Giallonardo, A Aggarwal, ... Antiviral Research 217, 105677, 2023 | 6 | 2023 |
| Clinical, Genomic, and Immunological Characterization of RSV Surge in Sydney, Australia, 2022 GJ Walker, CSP Foster, A Sevendal, A Domazetovska, A Kamalakkannan, ... Pediatrics 153 (2), 2024 | 5* | 2024 |
| Serological testing for infectious diseases markers of donor specimens from 24 h after death show no significant change in outcomes from other specimens CC Kok, V Ramachandran, E Egilmezer, S Ray, GJ Walker, ... Cell and Tissue Banking 21 (2), 171-179, 2020 | 5 | 2020 |
| Persistent high‐level shedding of cultivable SARS‐CoV‐2 Delta virus 33 days after onset of COVID‐19 in a hospitalized patient with pneumonia KW Kim, X Wang, A Adhikari, M Yeang, F Jenkins, Z Naing, GJ Walker, ... Journal of Medical Virology 94 (9), 4043-4046, 2022 | 4 | 2022 |
| Serological Detection of SARS-CoV-2 IgG Using Commercially Available Enzyme Immunoassays on Dried Blood Spots Collected from Patients GJ Walker, R Davis, Z Naing, B McEntee, Y Lu, T Denadija, ... Microbiology spectrum 9 (3), e01245-21, 2021 | 4 | 2021 |
| Transplacental transfer of RSV antibody in Australian First Nations infants N Homaira, M Binks, G Walker, N Larter, K Clark, M Campbell, L McHugh, ... Journal of Medical Virology 94 (2), 782-786, 2022 | 3 | 2022 |
